Found: 11
Select item for more details and to access through your institution.
Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
- Published in:
- Medical Mycology, 2022, v. 60, n. 2, p. 1, doi. 10.1093/mmy/myac003
- By:
- Publication type:
- Article
VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
- Published in:
- Medical Mycology, 2019, v. 57, n. 4, p. 434, doi. 10.1093/mmy/myy055
- By:
- Publication type:
- Article
The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 6, p. 1, doi. 10.1371/journal.pntd.0009488
- By:
- Publication type:
- Article
The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 12, p. 1, doi. 10.1371/journal.pntd.0008897
- By:
- Publication type:
- Article
Melanin production in coelomycetous agents of black grain eumycetoma.
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2021, v. 115, n. 4, p. 324, doi. 10.1093/trstmh/traa168
- By:
- Publication type:
- Article
Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 4, p. 1, doi. 10.1371/journal.pntd.0006437
- By:
- Publication type:
- Article
Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 4, p. 1, doi. 10.1371/journal.pntd.0008190
- By:
- Publication type:
- Article
Madurella real-time PCR, a novel approach for eumycetoma diagnosis.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 1, p. 1, doi. 10.1371/journal.pntd.0007845
- By:
- Publication type:
- Article
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
- Published in:
- Mycoses, 2022, v. 65, n. 6, p. 650, doi. 10.1111/myc.13442
- By:
- Publication type:
- Article
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.
- Published in:
- PLoS Neglected Tropical Diseases, 2022, v. 16, n. 2, p. 1, doi. 10.1371/journal.pntd.0010159
- By:
- Publication type:
- Article